Presented for research literature review only Svoboda Z et al
Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat
, [] Keywords: Carnitine
Signal Transduct Target Ther 8(1):168
If a clinical need to compound drug products using the bulk drug substance has not been demonstrated, based on the information submitted by the nominator and any other information considered by the Agency, FDA will not place the bulk drug substance on the 503B Bulks List. In making its decision on which of the nominated drugs are included on the list of permitted bulk drug substances, the FDA does not interpret supply issues, such as backorders, to be within the meaning of clinical need for compounding with a bulk drug substance
Reprod Biomed 30:101110 Maleki V, Jafari VH, Kashani A, Moradi F, Vajdi M, Kheirouri S, Alizadeh M (2019) Roles of carnitine in PCOS: a systematic review